Pustular psoriasis in a patient with Turner syndrome: profile of serum cytokine levels

Asahina, Akihiko; Uno, Kazuko; Fujita, Hideki

doi:10.1111/j.1365-4632.2011.05402.x

Cited by 6 publications

(8 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other skin conditions that have a greater prevalence include pilomatricomas (2.6%) (397, 398), vitiligo (2.7-6%) (399, 400) and halo nevi (18%) (399). Psoriasis is frequently reported in patients with TS, but a study of 594 women with TS did not find an increased prevalence over the general population (166,401). Clinical practice suggests that keloids commonly occur, but one report showed that only about 3% developed keloids or hypertrophic scars after surgical procedures (402).…”

Section: Dermatologymentioning

confidence: 99%

Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

Gravholt¹,

Andersen

Conway

et al. 2017

European Journal of Endocrinology

908

1,259

View full text Add to dashboard Cite

Turner syndrome affects 25-50 per 100,000 females and can involve multiple organs through all stages of life, necessitating multidisciplinary approach to care. Previous guidelines have highlighted this, but numerous important advances have been noted recently. These advances cover all specialty fields involved in the care of girls and women with TS. This paper is based on an international effort that started with exploratory meetings in 2014 in both Europe and the USA, and culminated with a Consensus Meeting held in Cincinnati, Ohio, USA in July 2016. Prior to this meeting, five groups each addressed important areas in TS care: 1) diagnostic and genetic issues, 2) growth and development during childhood and adolescence, 3) congenital and acquired cardiovascular disease, 4) transition and adult care, and 5) other comorbidities and neurocognitive issues. These groups produced proposals for the present guidelines. Additionally, four pertinent questions were submitted for formal GRADE (Grading of Recommendations, Assessment, Development and Evaluation) evaluation with a separate systematic review of the literature. These four questions related to the efficacy and most optimal treatment of short stature, infertility, hypertension, and hormonal replacement therapy. The guidelines project was initiated by the European Society of Endocrinology and the Pediatric Endocrine Society, in collaboration with the European Society for Paediatric Endocrinology, the Endocrine Society, the European Society of Human Reproduction and Embryology, the American Heart Association, the Society for Endocrinology, and the European Society of Cardiology. The guideline has been formally endorsed by the European Society of Endocrinology, the Pediatric Endocrine Society, the European Society for Paediatric Endocrinology, the European Society of Human Reproduction and Embryology and Summary of recommendationsThe recommendations (R) are worded as recommend (strong recommendation) and suggest (weak recommendation). We formally graded only the evidence underlying recommendations for therapeutic choices. The quality of evidence behind the recommendations is classified as very low (⨁◯◯◯), low (⨁⨁◯◯), moderate (⨁⨁⨁◯) and strong (⨁⨁⨁⨁). See further section 'Summary of methods used for guideline development'. Diagnosis and geneticsR 1.1. We recommend considering a diagnosis of TS in phenotypic females with a karyotype containing one X chromosome and complete or partial absence of the second sex chromosome, associated with one or more typical clinical manifestations of TS (⨁⨁⨁⨁). R 1.2. We recommend against considering a diagnosis of TS in females with one X chromosome and a deletion distal to Xq24 on the other X chromosome, and in women over the age of 50 years with less than 5% 45,X mosaicism (⨁⨁◯◯). R 1.3. We suggest that the new general surveillance management guideline applies to TS patients with any karyotype (⨁⨁◯◯). R 1.4. We recommend to consider testing for Turner syndrome (TS) in a female with typical signs (Table 2) (⨁⨁⨁⨁). R 1.5. We ...

show abstract

Section: Dermatologymentioning

confidence: 99%

Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

Gravholt¹,

Andersen

Conway

et al. 2017

European Journal of Endocrinology

908

1,259

View full text Add to dashboard Cite

show abstract

“…The observed mutation was previously described in a Dutch family with a typical EKV phenotype, 2 and in two Dutch patients with progressive symmetric erythrokeratodermia of Gottron (PSEK). 3 Interestingly, a microsatellite analysis in these Dutch patients with EKV/PSEK showed that the same allelic haplotype, extending over 2 Mb and including the GJB4 gene, was shared, even though these patients were from different families. 3 This result suggests that a single ancestral founder with this mutation might have introduced EKV with the p.G12D mutation to the Netherlands.…”

mentioning

confidence: 87%

“…Both TS patients and psoriasis patients are known to be characterized by a high prevalence of metabolic syndrome. 3 When our patient was 2 months old, she was diagnosed with TS at a pediatric clinic by genetic study of karyotyping. She was treated with a recombinant growth hormone until adolescence, which resulted in her reaching the height of 153 cm.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Generalized pustular psoriasis associated with Turner syndrome and dilated cardiomyopathy

Ito

Maejima

Okazaki

et al. 2016

The Journal of Dermatology

View full text Add to dashboard Cite

“…Although it is known that patients with TS sometimes develop psoriasis, the coexistence of TS and pustular psoriasis is rare with only a few cases reported. [1][2][3] Those previously reported cases affected adults, and hormonal changes such as estradiol were suggested as a causative factor. By contrast, we report on the first case of pediatric pustular psoriasis without hormone therapy.…”

Section: Pediatric Pustular Psoriasis With Turner's Syndromementioning

confidence: 99%

Pediatric pustular psoriasis with Turner's syndrome

Kato

Kanazawa

Yamamoto

2015

The Journal of Dermatology

View full text Add to dashboard Cite

Pustular psoriasis in a patient with Turner syndrome: profile of serum cytokine levels

Cited by 6 publications

References 9 publications

Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

Generalized pustular psoriasis associated with Turner syndrome and dilated cardiomyopathy

Pediatric pustular psoriasis with Turner's syndrome

Contact Info

Product

Resources

About